Correlation Between Molecular Partners and Rallybio Corp
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Rallybio Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Rallybio Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Rallybio Corp, you can compare the effects of market volatilities on Molecular Partners and Rallybio Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Rallybio Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Rallybio Corp.
Diversification Opportunities for Molecular Partners and Rallybio Corp
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Molecular and Rallybio is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Rallybio Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rallybio Corp and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Rallybio Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rallybio Corp has no effect on the direction of Molecular Partners i.e., Molecular Partners and Rallybio Corp go up and down completely randomly.
Pair Corralation between Molecular Partners and Rallybio Corp
Given the investment horizon of 90 days Molecular Partners AG is expected to under-perform the Rallybio Corp. In addition to that, Molecular Partners is 2.15 times more volatile than Rallybio Corp. It trades about -0.08 of its total potential returns per unit of risk. Rallybio Corp is currently generating about 0.03 per unit of volatility. If you would invest 104.00 in Rallybio Corp on August 28, 2024 and sell it today you would earn a total of 1.00 from holding Rallybio Corp or generate 0.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. Rallybio Corp
Performance |
| Timeline |
| Molecular Partners |
| Rallybio Corp |
Molecular Partners and Rallybio Corp Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Rallybio Corp
The main advantage of trading using opposite Molecular Partners and Rallybio Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Rallybio Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rallybio Corp will offset losses from the drop in Rallybio Corp's long position.| Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
| Rallybio Corp vs. Century Therapeutics | Rallybio Corp vs. Edgewise Therapeutics | Rallybio Corp vs. C4 Therapeutics | Rallybio Corp vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |